In contrast, in chronic myelocytic leukemia (CML), LINC00470 has been shown to bind METTL3 and positively regulate the m6A modification levels of PTEN mRNA, consequently downregulating ATG5 expression and leading to chemotherapy resistance [32]. Here, LINC00470 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.